| Literature DB >> 32455961 |
Borja Sañudo1, Adérito Seixas2, Rainer Gloeckl3,4, Jörn Rittweger5,6, Rainer Rawer7, Redha Taiar8, Eddy A van der Zee9, Marieke J G van Heuvelen10, Ana Cristina Lacerda11, Alessandro Sartorio12, Michael Bemben13, Darryl Cochrane14, Trentham Furness15, Danúbia de Sá-Caputo16,17, Mario Bernardo-Filho16.
Abstract
COVID-19 is a highly infectious respiratory disease which leads to several clinical conditions related to the dysfunction of the respiratory system along with other physical and psychological complaints. Severely affected patients are referred to intensive care units (ICUs), limiting their possibilities for physical exercise. Whole body vibration (WBV) exercise is a non-invasive, physical therapy, that has been suggested as part of the procedures involved with pulmonary rehabilitation, even in ICU settings. Therefore, in the current review, the World Association of Vibration Exercise Experts (WAVEX) reviewed the potential of WBV exercise as a useful and safe intervention for the management of infected individuals with COVID-19 by mitigating the inactivity-related declines in physical condition and reducing the time in ICU. Recommendations regarding the reduction of fatigue and the risk of dyspnea, the improvement of the inflammatory and redox status favoring cellular homeostasis and the overall improvement in the quality of life are provided. Finally, practical applications for the use of this paradigm leading to a better prognosis in bed bound and ICU-bound subjects is proposed.Entities:
Keywords: COVID-19; SARS-CoV-2; coronavirus; whole body vibration exercise
Mesh:
Year: 2020 PMID: 32455961 PMCID: PMC7277771 DOI: 10.3390/ijerph17103650
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Intervention parameters in the included studies.
| Author | Participants and Age (Years/Months/Weeks) ± SD or [SE] or (Min–Max) | Condition | Study Design | Frequency (Hz) | Amplitude or PPD (mm) | Peak Acceleration (m/s2 or g) | Vibration Type/Device | Position/Exercises | Session Protocol | Intervention | Footwear |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| EG1: n = 12 | Immobilized ICU patients | Clinical trial with longitudinal analysis (before, during, and after intervention) | EG1: 26 | 2–5 | No information | EG1: Synchronous vibration (Vibrosphere®, Promedvi: Sweden) | Supine position with knees flexed at about 20° | One session | EG1: 9 × 1 min, 45 s rest | Socks |
|
| n = 17 | Older people | Quasi-experimental, single-group, pretest-posttest design | 12 | 3 | No information | Vertical synchronous vibration (i-vib6050 model; Bodygreen, Changhua, Taiwan) | Stand on position | 3-Month period, 3 sessions/week | 10 × 60 s, 30 s rest | No information |
|
| EG1: n = 11, 55.2 [3.4] years | Fibromyalgia | RCT (2-factor mixed experimental design) | EG1: 30 | EG1: 2 | No information | Synchronous vibration (PowerPlate®, Power Plate North America, Inc., Northbrook, IL) | Static and dynamic lower extremities tasks (static and dynamic squat; ankle plantar-flexion with legs in extension; flexo-extension of the right leg or of the left leg; squat shifting the body weight from 1 leg to the other) | 6-Week period, 2 sessions/week | 3–6 × 4–18 min, 3 min rest | No information |
|
| EG1: n = 10, 58.8 ± 3.9 years | Parkinson’s disease | RCT | EG1: 26 | EG1: 4 | EG1: 106.64 m/s2 | Side alternating vibration (Galileo, Med L2000, Novotec Medical GmbH, Pforzheim, Germany) | Isometric protocol in semi squat position with normalized workload (20–100% patient’s body weight, progressive increase of 5% body weight was added every week) | 4-Week period, 4 sessions/week | 20 × 1 min, 1 min rest | No information |
|
| EG: n = 18, 55 (50–63) years | Allogeneic hematopoietic cell transplantation | RCT (subjects randomly allocated 1:1 to two parallel groups) | EG: 20–27 | EG: 0–3 | No information | Side alternating vibration (Galileo, Med L2000, Novotec Medical GmbH, Pforzheim, Germany) | Standing position: five exercises from a repertoire of 16 exercises for lower limbs, especially the knee extensors and flexors | 180-Day period, 5 sessions/week | ~20 min/session | Barefoot |
|
| EG: n = 16 | Reumatoid Arthitis | RCT | 30 | 3 | No information | Vertical synchronous vibration ((DKN XG 5.0, DKN Technology, California, USA) | Standing position holding on to the handlebars with knees slightly bent | 12 weeks | EG: WBV 10 × 60 s, 30 s rest | Barefoot |
|
| n = 17 | COPD | Non-randomised, cross-over design to sham | 25 | 2 | 24.7 m/s2 | Side alternating vibration platform (Amazing Super Health, Melbourne, AUS) | Static squatting position with knees flexed at about 20° | One session | 5 × 1 min, 1 min rest | Flat soled shoes |
|
| n = 10 | COPD | RCT cross-over study | 26 | 5 | No information | Side alternating vibration (Galileo, Novotec Medical, Pforzheim, Germany) | Dynamic squatting position with knees and hips at about 90–100° | One session | 6 × 3 min, 10 repetitions per minute (to bend their knees 2 s concentric, 2 s eccentric, 2 s standing between each repetition) | Flat soled shoes |
|
| n = 16 | COPD | non-randomized, cross-over design to sham | 25 | 2 | ~24.7 m/s2 | Side alternating vibration platform (Amazing Super Health, Melbourne, AUS) | 53° knee flexion | 6-Week period, 2 sessions/week | No information | Flat soled shoes. |
|
| n = 11 | Healthy male subjects | Single site, within subjects, pre and post-test design, cross-over | 35 | 4 | No information | Power Plate my3 (Power Plate North America, Northbrook, IL) | EG1: standing platform vibration; EG2: repetitive leg squat exercise (no vibration); and EG3: EG1 plus EG2 (with vibration) | 2 to 3-week period, one session | EG1: 8 bouts (WBV) × 60 s × 120 (rest), knees slightly bent; EG2: 8 bouts (WBV) × 60 s × 120 (rest), 90° knee flexion, 120 total repetitions of leg squats; EG3: same EG2 | Barefoot |
|
| EG: n = 10, 63.5 ± 7.8 years | COPD | Single-blind trial with a controlled parallel design | EG: 30–40 | EG: 2 | EG: 1.45–2.25 g | Synchronous vibration (Fitvibe Excel Pro C, Bilzen, Belgium) | Static squatting position with knees flexed at about 30° | 12-Week period, 3 sessions/week | 6 × 30 s, 60 s rest | Barefoot |
|
| EG: n = 19, 52.1 [1.8] years | Fibromyalgia | CT 1:1 case-control paired study (variables assessed before and immediately after one session) | EG: 40 | EG: 4 | No information | Synchronous vibration (Fitvibe Excel Pro C, Bilzen, Belgium) | Dynamic squatting position with knees flexed at about 10° to 60° | One session | 8 × 40 s, 40 s rest (to bend their knees to 60° angle for 3 s and then to 10° angle for 3 s, over the 40 s of each series) | Barefoot |
|
| EG1: n = 10, 75 ± 7.4 years | Knee osteoarthritis | Clinical, prospective, randomized, single-blinded study | EG1: 35–40 | EG1: 4 | EG1: 2.00-2.61 g | Synchronous vibration (Fitvibe Excel Pro C, Bilzen, Belgium) | Dynamic squatting position with knees flexed at about 10° to 60° | 12-Week period, 3 sessions/week | 6–8 × 20–40 s, 20–40 s rest (to bend their knees to 60° angle for 3 s and then to 10° angle for 3 s, over each series) | Barefoot |
|
| EG1: n = 11 (hum), 22–27 years | EG1: healthy individuals EG2: old C57BL/6 mice | Non-randomized study | EG1: 21 | No information | No information | Vertical vibration (Weibutexun, Jinan, China) | EG1: standing body vibration and seated for 10min in each position; EG2: no information | 4-week period, 7 sessions/week | EG1: 10 min (WBV); EG2: 30 min (WBV) | No information |
|
| EG1: n = 11, 33 ± 4 years | EG1: normal weight | Non-randomized study | 14 | 2.5 | 20.19 m/s2 | Side alternating whole body vibration platform | Static squat position, knee flexion (~60°) with a stable non-flexed trunk. | One session | 10 bouts × 60s (WBV) × 30 s (rest) | Barefoot |
|
| EG1: n = 8, | Knee osteoarthritis | Randomized controlled trial (variables assessed before and after training) | EG1: 35–40 | EG1: 4 | EG1: 2.78–3.26 g | Synchronous vibration (Fitvibe Excel Pro C, Bilzen, Belgium) | Dynamic squatting position with knees flexed at about 10° to 60° | 12-Week period, 3 sessions/week | 6–8 × 20–40 s, 20–40 s rest (to bend their knees to 60° angle for 3 s and then to 10° angle for 3 s, over each serie) | Barefoot |
|
| CG: n = 10, 33.4 ± 6.6 years | Healthy male | Randomized controlled trial | 19–30 | No information | No information | Side alternating vibration (Galileo Space, Novotec Medical, Pforzheim, Germany) | EG: squating exercise, heel raises, toe raises and kicks | 8-week, twice daily (except for Wednesday afternoons and Sundays) | Exercises were performed rhythmically at a repetition rate of 1 in 6 s, and kicks (explosive squats with 10 s rest insertion) | No information |
|
| CG: n = 20, 70.4 ± 10.1 years | COPD | Clinical trial | 12–26 | 1.5; 2; and 3 | No information | Side alternating vibration Galileo®, Novotec Medical, Pforzheim, Germany) | CG: physiotherapy program, EG: physiotherapy program plus WBV (bended knees on the Platform) | No information | 3 × 2 min/day | No information |
|
| EG1: n = 12, 8.6 ± 3.2 months | Cerebral palsy | Prospective, evaluator-blinded, monocenter, randomized waiting-control design with follow-up | 12 or 22 | 2.5 | 0.72 g or 2.43 g | Side alternating vibration Galileo® system combined with a tilt table (Novotec Medical GmbH, Pforzheim, Germany) | Standing still or alternately squatting and standing up (using tilt table); sitting on the platform; four-point position | 14-week, twice daily (10 times per week) | Ten 9-minute (3 × 3) min | If possible the children trained without shoes, but with socks |
|
| CG: n = 37, | COPD | Randomized controlled trial | 24–26 | 5 PPD | No information | Side-alternating vibration platform Galileo® (Novotec Medical GmbH, Pforzheim, Germany) | Dynamic squat training, 90° and 120° Knee and hip flexion during each squat movement without holding on to anything | 3-week, 3 times a week (non-consecutive days) | 4 bouts × 120 s (WBV) | Flat soled shoes |
|
| n = 12, | Healthy individuals | Non-randomized study | 26 | 6 | No information | Side alterning vibration Galileo, 2000 (Novotec Medical GmbH, Pforzheim, Germany) | Standing, squatting, and squatting with a load | One session | Exercises performed in randomized sequence for 3 min each | No information |
|
| EG1: n = 8, | Healthy RA men | Non-randomized study | 45 | 2 | No information | Vertical vibration WAVE platform (Whole-body Advanced Vibration Exercise, Windsor, Canada) | EG1: seated next to the WBV device (passive, unloaded), 90º knee flexion | One session | EG1 and EG2: | Barefoot |
|
| EG1: n = 12, 41.8 ± 19.7 years | EG1: ICU patients | Non-randomized study | 24 | No information | No information | Side alternating vibration Galileo® (Novotec Medical, Pforzheim, Germany) | EG1 and EG2: WBV alone and WBV with a dumbbell | One session | EG1 and EG2: | Barefoot |
|
| Males: n = 9, | Healthy individuals | Single-group, repeated-measure, cross-study | 0, 10, 20 | No information | No information | Side alternating vibration Galileo® (Novotec Medical, Pforzheim, Germany) | Three pelvic positions (neutral, anterior tilt, posterior tilt) | One session | 3 × 10 s (WBV) × 10 s (rest) in each position | No information |
|
| EG1 and EG2: n = 18, 25 ± 4 years | Healthy individuals | Single-group, repeated measures, crossed-study | EG1 and EG2: 5, 10, 15, 20, 25, 30 | EG 1: 2 and 4 EG2: 2 | No information | EG1: Novotec Medical (Pforzheim, Germany); EG2: Power Plate. (Germany, Frankfurt am Main, Germany) | One session | EG1: side alternating vibration and EG2: synchronous vibration: 10 s (WBV) × 30 s (rest) | Barefoot | |
|
| n = 14 | Physically active men | Randomizedcross-over | 22 | Mean 4 (feet at shoulder width) | No information | Side-alternating Galileo 900 (Novotec, Pforzheim, Germany) | Squat exercise knee bending angle 80° and additional load 10RM applied by barbell | One session | EG: WBV 5 sets of 10 squats within 30 s per set. 3 min rest between sets | Shoes |
|
| n = 9 male | Healthy adults | Single-group repeated measures | 30 | 2 | No information | Vertical: Powerplate Power Plate North America, Inc., Northbrook, IL) and side-alternating: Galileo 2000 (Novotec Medical, Pforzheim, Germany) | Slow dynamic squatting movement from 5° to 40° knee flexion for several | One session | Two trials for in max 15 s per condition. 60s rest between trials, 5 min rest between vibration directions | Sport socks |
|
| n = 3, | Patients fractured lumbar vertebral body, male | Repeated measures | 5–25 | 1, 2, 4 | No information | Vertical: Powerplate Pro 5. (Power Plate North America, Inc., Northbrook, IL). Side-alternating: Galileo advanced (Novotec Medical, Pforzheim, Germany) | 4 postures: knees straight, knees slightly bent, knees bent at 60° and on the forefeet | One session | 8 WBV trials on each plate, 12–15 s per trial, One trial 60 s. Breaks between trials 10-30s, break 5 min when changing device | No information |
|
| EG1: n = 12 | Healthy adults | Single group repeated measures Randomized order | 5–30 | 5.5 and 2.5 | 0.2–9 g | Side-alternating Galileo 2000 (Novotec Medical GmBH, Pforzheim, Germany) | Standing straight legs, without locking knees, resulting in 15.1 ± 4.8° knee flexion | One session | EC: WBV 7s for each condition (6 frequencies x 2 amplitudes) | Barefoot |
|
| EG + CG: n = 11 | COPD, 72.7% male | Cross-over RCT | 35 | 2 or 4 | No information | Vibrating platform (MY3; Power Plate, London, UK) | Static work of the lower limbs, semi squatting position at an angle of 120°–130° with the upper limbs lightly flexed in support | 12 weeks 3 sessions/week | EG: 1–4 wks (10 min; 30 s WBV × 60 s rest); 5-8 wks (15 min); 9-12 wks (20 min; 60 s WBV × 30 s rest) | No information |
|
| EG: n = 42 | COPD, 51% female | RCT | 24–26 | 3 | No information | Side-alternating Galileo® (Novotec Medical GmbH, Pforzheim, Germany) | Squat exercises | 3 weeks | EG: WBV 3 × 3 min CG: same exercises on floor | No information |
|
| EG + CG: n = 20 | C57BI/6 mice, males | RCT | 30 | 0.0537 | 0.098 g | Synchronous, 3D LEVELL R.C. Oscillator | Free choice | 5 weeks | EG: WBV | No information |
|
| n = 133 | Healthy young adults, 84% female | Cross-over Short-term effects | 30 | 0.5 | No information | Vertical/Vibe 300 (Tonic Vibe, Nantes, France) with chair | Sitting | One session | EG: WBV 6 × 2 min CC: rest 6 × 2 min | Socks |
|
| n = 18 | Healthy young male adults | Cross-over Acute effects | 10, 20, 27 | 4 | No information | Side-alternating/Galileo® Advanced Plus (Novotec Medical GmbH, Pforzheim, Germany) | Static half squat 30° flexion Standing | One session | EG: WBV 3 conditions × 2 tasks each 5 × 30 s CG: same position without WBV | No information |
|
| EG + CG: n = 14 | Young C57BI/6J mice, males | RCT | 30 | 0.0537 | 0.098 g | Synchronous, 3D LEVELL R.C. Oscillator (Levell Electronics Ltd, Barnet, GB) with Shaker power amplifier | Free choice | 5 weeks | EG: WBV 1 × 10 min | No information |
|
| EG + CG: n = 25 | mouse model of Parkinson’s disease | RCT | 10 and 30 | 5 | No information | Synchronous Platform (Columbus instruments, OH, USA) | Free choice | 4 weeks | EG1: 5 mm/10 Hz: 15 × 1 min WBV, rest 1min | No information |
SD-standard derivation; SE-standard error; Min-minimum; Max-maximum; PPD-peak-to-peak displacement; ICU-intensive care unit; wks-weeks; COPD-chronic obstructive pulmonary disease; WBV-whole body vibration; s-second; hum-humam; anim-animals; RA-recreationally active; min-minute.
Figure 1Conventional squat exercise on a WBV platform [54].
Figure 2(A): WBV exercise in conscious but bed-bound ICU patients. Tilt ICU bed up to 30° and fix WBV platform at the end of the bed. Knees should be slightly bended for about 10°. Considerable muscle contractions at the calf and thigh muscles should be noticed by the patient (figure adapted from [44]). (B): WBV exercise in unconscious bed-bound ICU patients. Fix the legs with a strap to get pressure on the platform. Flex knees and hip for about 20°. Considerable muscle contractions at the calf and thigh muscles should be noticeable by a therapist (figure adapted from [13]).
Training termination criteria [13].
| Parameter | Value |
|---|---|
| Heart rate | <40 or >180 BPM |
| Systolic blood pressure | <80 mmHg or >200 mmHg; |
| Mean arterial blood pressure | <60 mmHg or >120 mmHg |
| Increase in intracerebral pressure | >20 mmHg |
| Oxygen saturation (SpO2) | <88% |
| Potassium levels | <3.0 mmol/L or >5.5 mmol/L |
Static loading as percentage of body weight (BW) depending on tilt angle.
| Tilt Angle | % Load |
|---|---|
| 10° | 17% BW |
| 20° | 34% BW |
| 30° | 50% BW |
| 60° | 87% BW |
| 80° | 97% BW |
Parameters to alter training intensity for side-alternating and vertical whole-body vibration training devices [13,44,73].
| Parameter | Value |
|---|---|
| 1 to 2 | |
| Times per day | Standard ICU bed (severe cases): |
| 0° tilt + 20° knee angle | |
| 30° tilt + bent knees | |
| Tilt Angle | Special Tilt-Table (less severe cases): |
| 30° to 90° | |
| Standing device (further increase of intensity): 90° (standing) | |
| Frequency | Side-alternating WBV: 20 to 27 Hz Vertical WBV: 25 to 35 Hz |
| Duration | 1 to 3 min |
| Number of sets | 1 to 4 |
| Amplitude (peak-to peak) | Side-alternating WBV: 1–2.5 mm (2–5 mm) Vertical WBV: 1 mm (2 mm) |
| Further increase of intensity by additional exercise tasks | Squatting (hip & thigh muscles) |
| Heel-raises (calf muscles) | |
| Toe-raises (shin-muscles) | |
| Pelvis lifting (thigh muscles & trunk) |